Psychiatr. praxi 2017; 18(2): 60-63 | DOI: 10.36290/psy.2017.011
Cognitive dysfunction frequently occurs in acute depression and can persist into remission. Cognitive impairments impacts on
patient functioning and negatively influence ability to perform adequately at work. As evidenced by the results of numerous
studies drugs with anticholinergic effect (e. g. tricyclic antidepressants) may adversly affect cognitive functions. The most frequently
prescribed antidepressants, selective serotonin reuptake inhibitors may improve cognitivy dysfunction in depression.
Agent also including a noradrenergic component such as selective serotonin and noradrenaline reuptak inhibitorts appears to
be more effective in respect to cognitive functions compared to SSRI treatment. Based on the available data, the new multimodal
antidepressant vortioxetine may have a specific pro-cognitive effects.
Published: July 1, 2017 Show citation